Beijing SL Pharmaceutical (002038.SZ) announced that Liang Shujie, director and board secretary of the company, plans to reduce his shareholding by centralized bidding trading from July 16, 2024, to October 15, 2024.
According to the announcement made by Beijing SL Pharmaceutical (002038.SZ), Liang Shujie, director and board secretary of the company, plans to reduce his shareholding by no more than 500,200 shares through centralized bidding trading from July 16, 2024, to October 15, 2024.